Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by ETalien on Apr 29, 2021 9:35am

I must say…

We all have stock in CLARITAS except for the CONS on here. I must say it has been a real disappointment with regards to the PPS.  Other companies with less to offer are increasing daily and CLAS seems to be a sell? I'm at a loss! Companies that come out with news of testing see their share price rise! We have a FRIKIN solution basically and we deep dive like a submarine getting away from an enemy! I'm at a loss! My RANT for the day!
Comment by WORKINMONTANA on Apr 29, 2021 9:58am
Large financially backed Countries/companies force companies with leading edge technology into insolvency all the time across the world.  It could be China, South Korea, Hong Kong firms or even the Cartel in Columbia.  No one will know who sells millions upon millions of shares into the open market to keep Claritas market cap at mere pennies all these years. Their MC should be upwards of ...more  
Comment by ETalien on Apr 29, 2021 10:09am
I'm gathering you are not referring to me as a FAT TROLL, correct? 
Comment by PTBailey on Apr 29, 2021 10:29am
I am pretty new to the investment world and these online forums. I don't get why someone would make a logical arguement or point and then resort to name calling and insults directed to others with a counter point of view. It diminishes the power of their point by portraying themselves as rude, ignorant and disrespectful and not to be taken seriously.
Comment by whisky11 on Apr 29, 2021 11:12am
PTBailey wrote: I am pretty new to the investment world and these online forums. I don't get why someone would make a logical arguement or point and then resort to name calling and insults directed to others with a counter point of view. It diminishes the power of their point by portraying themselves as rude, ignorant and disrespectful and not to be taken seriously. whisky11: bashers and ...more  
Comment by Red~One on Apr 29, 2021 11:21am
Would that strategy apply to Pumpers as well ?
Comment by whisky11 on Apr 29, 2021 11:23am
Red~One]Would that strategy apply to Pumpers as well ? whisky11:No
Comment by Exjumper on Apr 29, 2021 2:09pm
This post has been removed in accordance with Community Policy
Comment by PTBailey on Apr 29, 2021 2:12pm
That makes sense.
Comment by whisky11 on Apr 29, 2021 2:21pm
PTBaley wrote: That makes sense. whisky11: thanks for understanding. I hope , problem with bashers will be over soon. When the stock goes up, somehow  conversation become more civilized.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities